A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: not capable (45), powerless (1), incapable (7)

Myeloma VCD (IV35) bortezomib (IV) cyclophosphamide dexamethasone 35 day

Description
Chemotherapy Protocol MULTIPLE MYELOMA VCD (IV-35) - BORTEZOMIB (IV)-CYCLOPHOSPHAMIDE-DEXAMETHASONE (35 day) Regimen Multiple Myeloma – V
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Myeloma-VCD-IV35-bortezomib-IV-cyclophosphamide-dexamethasone-35-day.pdf

DVd Weekly Daratumumab-Bortezomib-Dexamethasone weekly Cycles 9 onwards

Description
Chemotherapy Protocol Myeloma DVd (weekly) Bortezomib-Daratumumab-Dexamethasone (cycles 9 onwards) Regimen • Myeloma – Bortezomib (wee
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVd-Weekly-Daratumumab-Bortezomib-Dexamethasone-weekly-Cycles-9-onwards.pdf

Binimetinib-Encorafenib

Description
Chemotherapy Protocol SKIN CANCER Binimetinib-Encorafenib Regimen • Skin – Binimetinib-Encorafenib Indication • Unresectable or metas
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Binimetinib-Encorafenib.pdf

CH003 regimen validation checklist ver2.0x

Description
Central South Coast Cancer Network Strength through Partnership Checklist for Verification of Treatment Regimens in ARIA Version 10 Regimen’s Name and Di
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Validation/CH003regimenvalidationchecklistver20x.pdf

Mental wellbeing support on the neonatal intensive care unit (NICU) - patient information

Description
Patient information factsheet Mental wellbeing support on the neonatal intensive care unit (NICU) If your
Url
/Media/UHS-website-2019/Patientinformation/Neonatal/Mental-wellbeing-support-on-the-neonatal-intensive-care-unit-NICU-2291-PIL.pdf

Cystic fibrosis diabetes - patient information

Description
This factsheet explains what to expect when you are tested for cystic fibrosis diabetes (CFD).
Url
/Media/UHS-website-2019/Patientinformation/Medicinestherapiesandanaesthetics/Cystic-fibrosis-diabetes-2635-PIL.pdf

Pulmonary vein isolation radiofrequency ablation - patient information

Description
Patient information factsheet Pulmonary vein isolation (PVI) ablation Your doctor has recommended you have the above
Url
/Media/UHS-website-2019/Patientinformation/Heartandlungs/Pulmonaryveinisolationradiofrequencyablation-725-PIL.pdf

Welcome to Bursledon House - patient information

Description
We have written this factsheet for parents as a guide to your child's careand education while they are at Bursledon House
Url
/Media/UHS-website-2019/Patientinformation/Childhealth/Welcome-to-Bursledon-House-2526-PIL.pdf

Keeping your baby safe - patient information

Description
We have written this factsheet to make sure your baby is cared for as safely as possible, outside and at home
Url
/Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Keeping-your-baby-safe.pdf

Acalabrutinib

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia Regimen Acalabrutinib • CLL – Acalabrutinib Indication • First-line treatment
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Acalabrutinib.pdf
411 to 420 of 438
Previous … 40 41 42 43 44 Next